Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001178913-21-001652
Filing Date
2021-05-07
Accepted
2021-05-07 17:05:54
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 zk2126001.htm 424B5 381749
2 EXHIBIT 1.2 exhibit_1-2.htm EX-1.2 223553
3 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 13267
4 image0.jpg GRAPHIC 75730
5 image1.jpg GRAPHIC 76115
6 image00002.jpg GRAPHIC 5686
7 image2.jpg GRAPHIC 13577
  Complete submission text file 0001178913-21-001652.txt   855574
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239843 | Film No.: 21903818
SIC: 2836 Biological Products, (No Diagnostic Substances)